The constant turnover of body tissues requires the <u>chemical energy </u>supplied by carbohydrates, proteins, and lipids.
<h3> What is Chemical energy?</h3>
- The bonds of chemical molecules contain energy.
- Exothermic reactions are those in which chemical energy is released during the reaction, frequently in the form of heat.
- Some of the heat energy needed for a reaction to continue can be stored as chemical energy in newly created bonds.
- The body transforms the chemical energy in food into heat and mechanical energy.
- At a power plant, coal's chemical energy is transformed into electrical energy. Through the process of electrolysis, the chemical energy in a battery can also generate electricity.
Learn more about chemical energy here:
brainly.com/app/ask?q=CHEMICAL+ENERGY%2BVERIFIED+ANSWERS
#SPJ4
Answer: Only 10 percent of energy in a light bulb is used to create light. ...
The amount of energy Americans use doubles every 20 years. ...
Explanation:
Answer:
D
Explanation:
the circulatory absorbs nutrients and carries the chemical to signal through endocrine to control the speed of digestion.
The thermodynamic barrier that must be overcome before products are formed in spontaneous reaction is activation energy.
The activation energy is the maximum amount of extra energy that is required by a reacting molecules to get converted into product. It is the minimum energy that is required or needed to activate or energize molecules or atoms.
It is needed in the reaction so that reactants can move together and overcome forces of repulsion and start bond breaking.
Reactant is the substance that takes part in and that undergoes change during a reaction.
To learn more about reactant here
brainly.com/question/17096236
#SPJ4
Answer:
Explanation:
The more similar the two species are, the more their niche overlaps and the more competition there is.
<em>The most interesting results obtained in animal models of passive immunotherapies developed according to the “amyloid-beta cascade hypothesis” and the “Tau hypothesis” are monoclonal antibodies that directly or indirectly target Aβ plaques or neurofibrillary tangles. Unfortunately, these therapeutic antibodies cannot replicate their promising effects on humans at the clinical phase. Despite this, we still hope to learn from these failures and to explore new pathways. The great effects obtained in animals with passive immunotherapy suggest that this technology may be an important key to curative treatment. The remaining challenge is to find a way to achieve the same encouraging results for humans. Alzheimacy expects to join hands with global partners to focus on the development of therapeutic antibodies for Alzheimer’s disease (AD) and continue to fight against this disease.</em>
<em>https://www.creativebiomart.net/alzheimacy/therapeutics/therapeutic-antibody/</em>
